Entera Bio Ltd (ENTX)
NASDAQ:ENTX
Total Valuation
Entera Bio has a market cap or net worth of $51.75M. The enterprise value is $45.66M.
Market Cap$51.75M
Enterprise Value$45.66M
Share Statistics
Entera Bio has 46,622,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,622,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Entera Bio’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -218.81%.
Return on Equity (ROE)-0.87
Return on Assets (ROA)-0.72
Return on Invested Capital (ROIC)-218.81%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee2.33K
Profits Per Employee-635.50K
Employee Count18
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Entera Bio is ―. Entera Bio’s PEG ratio is 0.00.
PE Ratio―
PS Ratio2133.59
PB Ratio6.84
Price to Fair Value6.84
Price to FCF-11.98
Price to Operating Cash Flow-2.60
PEG Ratio0.00
Income Statement
In the last 12 months, Entera Bio had revenue of 42.00K and earned -11.44M in profits. Earnings per share was -0.25.
Revenue42.00K
Gross Profit-30.00K
Operating Income-11.53M
Pretax Income-11.44M
Net Income-11.44M
EBITDA-11.50M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -20.24M and capital expenditures -110.65K, giving a free cash flow of -20.36M billion.
Operating Cash Flow-20.24M
Free Cash Flow-20.36M
Free Cash Flow per Share-0.44
Dividends & Yields
Entera Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change-33.93%
50-Day Moving Average1.35
200-Day Moving Average1.90
Relative Strength Index (RSI)43.74
Average Volume (3m)123.78K
Important Dates
Entera Bio upcoming earnings date is May 8, 2026, After Close (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Entera Bio as a current ratio of 3.23, with Debt / Equity ratio of 3.74%
Current Ratio3.23
Quick Ratio3.23
Debt to Market Cap<0.01
Net Debt to EBITDA0.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Entera Bio has paid 11.53M in taxes.
Income Tax11.53M
Effective Tax Rate-1.01
Enterprise Valuation
Entera Bio EV to EBITDA ratio is -7.22, with an EV/FCF ratio of -11.10.
EV to Sales1.98K
EV to EBITDA-7.22
EV to Free Cash Flow-11.10
EV to Operating Cash Flow-11.26
Balance Sheet
Entera Bio has $7.11M in cash and marketable securities with $490.00K in debt, giving a net cash position of $6.62M billion.
Cash & Marketable Securities$7.11M
Total Debt$490.00K
Net Cash$6.62M
Net Cash Per Share$0.14
Tangible Book Value Per Share$0.28
Margins
Gross margin is -35.71%, with operating margin of -27450.00%, and net profit margin of -27235.71%.
Gross Margin-35.71%
Operating Margin-27450.00%
Pretax Margin-27235.71%
Net Profit Margin-27235.71%
EBITDA Margin-27378.57%
EBIT Margin-27450.00%
Analyst Forecast
The average price target for Entera Bio is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside800.90% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast25.25%
EPS Growth Forecast5.96%